1-(2-Methylpropyl)-4-piperidone | CAS:72544-16-2

We serve 1-(2-Methylpropyl)-4-piperidone CAS:72544-16-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-(2-Methylpropyl)-4-piperidone

Chemical Name:1-(2-Methylpropyl)-4-piperidone
CAS.NO:72544-16-2
Synonyms:1-(2-Methylpropyl)-4-piperidone
1-(2-methylpropyl)piperidin-4-one
 
Physical and Chemical Properties:
Density 0.914 g/mL at 25 °C(lit.)
Boiling Point 220 °C(lit.)
Molecular Formula C9H17NO
Molecular Weight 155.23700
Flash Point 200 °F
 
Specification:
Appearance:Yellow liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Rifabutin.



Contact us for information like 1-(2-Methylpropyl)-4-piperidone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(2-methylpropyl)piperidin-4-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(2-Methylpropyl)-4-piperidone Use and application,1-(2-methylpropyl)piperidin-4-one technical grade,usp/ep/jp grade.


Related News: In the process of fine chemical industry transfer, intermediates are a very important category, and they are also the main link for China to undertake transfers.(S)-3-Amino-3-phenylpropionic acid manufacturer There are a number of common signs that you may be infected, most of which are respiratory such as experiencing breathing difficulties, shortness of breath and having a cough.[4-(pyrrolidin-1-ylsulfonylmethyl)phenyl]hydrazine,hydrochloride supplier Pharmaceutical intermediates and APIs belong to the fine chemical industry.3-Cyanobenzylchloride vendor The national airlines of Egypt, Qatar and Saudi Arabia have halted flights to and from China.Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.